White House claims Speaker Nancy Pelosi’s drug pricing bill would result in 100 fewer drugs over a decade

CNBC News

3 December 2019 - The report from the administration suggests far greater consequences for both the drug industry and American consumers if Pelosi’s bill is enacted.

The White House, citing an analysis from the Council of Economic Advisers, an agency within the executive office, also said Pelosi’s bill would lead to worse health outcomes and cost the U.S. economy $1 trillion per year over that time period.

The report from the administration, which has some health policy analysts scratching their heads, suggests far greater consequences than other estimates for both the drug industry and American consumers if the bill is enacted.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing , Innovation